Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

677 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Healing of ExcisionAl wounds on Lower legs by Secondary intention (HEALS) cohort study. Part 1: a multicentre prospective observational cohort study in patients without planned compression.
Pynn EV, Ransom M, Walker B, McGinnis E, Brown S, Gilberts R, Trehan P, Jayasekera PSA, Veitch D, Hussain W, Collins J, Abbott RA, Chen KS, Nixon J. Pynn EV, et al. Among authors: chen ks. Clin Exp Dermatol. 2022 Oct;47(10):1829-1838. doi: 10.1111/ced.15273. Epub 2022 Jul 24. Clin Exp Dermatol. 2022. PMID: 35652236 Free PMC article. Clinical Trial.
Healing of ExcisionAl wounds on Lower legs by Secondary intention (HEALS) cohort study. Part 2: feasibility data from a multicentre prospective observational cohort study to inform a future randomized controlled trial.
Gilberts R, McGinnis E, Ransom M, Pynn EV, Walker B, Brown S, Trehan P, Jayasekera P, Veitch D, Hussain W, Collins J, Abbott RA, Chen KS, Nixon J. Gilberts R, et al. Among authors: chen ks. Clin Exp Dermatol. 2022 Oct;47(10):1839-1847. doi: 10.1111/ced.15283. Epub 2022 Jul 27. Clin Exp Dermatol. 2022. PMID: 35662230 Free PMC article. Clinical Trial.
Taldefgrobep Alfa and the Phase 3 RESILIENT Trial in Spinal Muscular Atrophy.
Servais L, Lair LL, Connolly AM, Byrne BJ, Chen KS, Coric V, Qureshi I, Durham S, Campbell DJ, Maclaine G, Marin J, Bechtold C. Servais L, et al. Among authors: chen ks. Int J Mol Sci. 2024 Sep 24;25(19):10273. doi: 10.3390/ijms251910273. Int J Mol Sci. 2024. PMID: 39408601 Review.
DICER1-Related Tumor Predisposition: Identification of At-risk Individuals and Recommended Surveillance Strategies.
Schultz KAP, Nelson AT, Mallinger PHR, Harris AK, Kamihara J, Baldinger S, Chen KS, Pond D, Hatton JN, Dybvik A, Mitchell SG, Perrino MR, Ben-Ami T, Kachanov D, Su Y, Duan C, Olson DR, Watson D, Field AL, Harney LA, Garrity Carr A, Frazier AL, Schneider DT, Wilson DB, MacFarland SP, Schoettler PJ, Bauer AJ, Dehner LP, Hill DA, Stewart DR, Messinger YH. Schultz KAP, et al. Among authors: chen ks. Clin Cancer Res. 2024 Oct 14. doi: 10.1158/1078-0432.CCR-24-1532. Online ahead of print. Clin Cancer Res. 2024. PMID: 39400264
677 results